New AI model could speed rare disease diagnosis
On Nov. 24, 2025, a new AI model called popEVE developed by Harvard Medical School researchers and colleagues…
-
-
Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
-
MIT researchers invent new human brain model to enable disease research, drug discovery
On Nov. 5, 2025, MIT researchers announced they have developed a new 3D human brain tissue platform, the…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approves menin inhibitor for patients with acute leukemia with NPM1 mutation, backed by Dana-Farber science
On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…
-
Genetic variant increases risk of heart muscle disease common in individuals of African ancestry
On Oct. 31, 2025, investigators from Mass General Brigham, the Broad Institute of MIT and Harvard, and VA…
-
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
-
Artificial Intelligence | Biotechnology | Chemistry | Energy | Genomics | Infectious Disease | Medical Device | Neurology | Oncology | Pharmaceutical | Stem Cell | Therapeutics | Vaccine
Leiden Report Show Universities in China Dominate Top Ten Rankings
On Oct. 29, 2025, the CWTS Leiden ranking show that Harvard University dropped to third place in the…
-
Ancient DNA Database Faces Uncertain Future after Funding Expires
On Oct. 23, 2025, researchers at a Harvard Medical School laboratory announced they are uncertain how they will…
-
Alkermes Announces Agreement to Acquire Avadel Pharmaceuticals for $2.1 billion
On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…
-
Blackstone, and TPG announce plans to take medtech Hologic private for $18.3 billion
On Oct. 21, 2025, private equity firms Blackstone and TPG said they will buy medical diagnostics firm Hologic…
-
Boston Scientific Announces Agreement to Acquire Nalu Medical for $533 million
On Oct. 17, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Nalu Medical,…
-
Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing technique
On Oct. 15, 2025, Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, announced…
-
UMass Engineers Create First Artificial Neurons That Could Directly Communicate With Living Cells
On Sept. 30, 2025, a team of engineers at the University of Massachusetts Amherst announced the creation of…
-
Biogen to Acquire Alcyone Therapeutics for $85 million, Expanding Drug Delivery Solution Portfolio
On Sept. 18, 2025, Biogen announced it has has entered into a definitive agreement to acquire Massachusetts-based Alcyone…
-
Biogen Receives EC Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
On Sept. 17, 2025, Biogen announced that the European Commission (EC) has granted marketing authorization for ZURZUVAE® (zuranolone)…
-
gene therapy offers hope for genetic hearing loss
On Sept. 14, 2025, scientists from the Gray Faculty of Medical & Health Sciences at Tel Aviv University…
-
Elutia Announces Sale of BioEnvelope Business to Boston Scientific for $88 Million
On Sept. 9, 2025, Elutia announced it has entered into a definitive agreement to sell its EluPro™ and…
-
eGenesis Announces IND Clearance for EGEN-2784 in Pig Kidney Transplant and Landmark Patient Updates in Ongoing Expanded Access Study
On Sept. 8, 2025, eGenesis announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational…
-
MannKind to Acquire scPharmaceuticals for $360 million
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
-
Skyhawk Therapeutics Announces Strategic Collaboration with Merck to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders
On Aug. 18, 2025, Skyhawk Therapeutics announces a strategic research collaboration with Merck KGaA, Darmstadt, Germany. The collaboration…
-
Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI
On Aug. 14, 2025, Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines…
-
Biology | Biotechnology | Diagnostics | FDA | Imaging | Marine Science | Medical Device | Pharmaceutical
Horseshoe Crabs Break Free from Biomedical Testing
On Jul. 29, 2025, The Scientist reported that for 40 years, researchers relied on horseshoe crab blood to…
-
Scientists apply optical pooled CRISPR screening to identify potential new Ebola drug targets
On Jul. 24, 2025, researchers at the Broad Institute and the National Emerging Infectious Diseases Laboratories (NEIDL) at…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Therapeutics | Vaccine
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
On Jul. 22, 2025, AstraZeneca announces $50 billion of investment in the United States by 2030, building on…
-
Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park
On Jul. 21, 2025, Biogen announced it intends to invest an additional $2 billion in its existing manufacturing…
-
Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures
On Jul. 14, 2025, Lab equipment maker Waters Corp said it will buy a bioscience and diagnostics unit…
-
Scientists discover compounds that help cells fight a wide range of viruses
On Jul. 14, 2025, Researchers at MIT and other institutions have identified compounds that can fight off viral…
-
A bionic knee integrated into tissue can restore natural movement
On Jul. 10, 2025, MIT researchers announced they have developed a new bionic knee that can help people…
-
Implantable device could save diabetes patients from dangerously low blood sugar
On Jul. 9, 2025, MIT engineers announced they have designed an implantable reservoir that can remain under the…
-
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
On Jul. 7, 2025, KalVista Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has approved EKTERLY® (sebetralstat),…
